Cledomax Susp

Description

CLEDOMOX 228MG/5ML SUSP
This medication is indicated for the treatment of the following infections caused by susceptible strains of the designated bacteria: Sinusitis caused by β-lactamase-producing strains of H. influenzae or Moraxella (Branhamella) catarrhalis. Otitis Media caused by β-lactamase-producing strains of H. influenzae or Moraxella (Branhamella) catarrhalis. Lower Respiratory Tract Infections caused by β-lactamase-producing strains of H. influenzae, K. pneumoniae, S. aureus, or Moraxella (Branhamella) catarrhalis. Skin and Soft Tissue Infections caused by β-lactamase-producing strains of S. aureus. Urinary Tract Infections caused by β-lactamase-producing strains of E. coli.

ADDED INFORMATION
It also contains Microcrystalline cellulose, sodium starch glycolate, anhydrous colloidal silica etc.

CONTRAINDICATIONS
Hypersensitivity to any of the ingredients
Infectious mononucleosis either suspected or confirmed.
A previous history of amoxicillin-associated jaundice/hepatic dysfunction.

DOSAGE
In infants 12 weeks (3 months) of age or older and in children.
Urinary tract Mild to moderate: 25 mg/kg/day in divided doses every 12 hours .
Skin and Soft Tissue Severe: 45 mg/kg/day in divided doses every 12 hours.
Lower Respiratory Tract: 45 mg/kg/day in divided doses every 12 hours. 

POSSIBLE SIDE EFFECTS
This drug may cause stomach and abdominal pain, vomiting, and diarrhea, as well as rash, hyperactivity, or drowsiness. Report any worsening side effects or those that last more than a few days to the pharmacist or physician.

WARNING
Prolonged use may lead to supra-infections
Prolonged use may also occasionally result in overgrowth of non-susceptible organisms.

STORAGE
Store below 25oC. Keep reconstituted product in the fridge, and discard after 7 days.  Protect from sunlight and heat.

Additional information